共 49 条
- [42] Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study [J]. International Journal of Hematology, 2012, 96 : 84 - 93
- [43] Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (01) : 84 - 93
- [48] Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (10): : 1488 - 1494
- [49] USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR BEFORE, DURING, AND AFTER FLUDARABINE PLUS CYTARABINE INDUCTION THERAPY OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROMES - COMPARISON WITH FLUDARABINE PLUS CYTARABINE WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) : 671 - 678